Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Long-term efficacy and safety of perampanel in patients aged 60 years and older with focal seizures: Post hoc analysis of phase III open-label extension studies stratified by enzyme-inducing anti-seizure medication use.
Journal: Epilepsy & behavior reports
Published: May 19, 2025
Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.
Journal: Epilepsia open
Published: December 20, 2023
Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: The PERMIT Extension study.
Journal: Epilepsy & behavior : E&B
Published: May 30, 2023
Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open-label study.
Journal: Epilepsia
Published: March 02, 2023
Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program.
Journal: Epilepsia
Published: September 23, 2022
Perampanel monotherapy for the treatment of epilepsy: Clinical trial and real-world evidence.
Journal: Epilepsy & behavior : E&B
Published: January 05, 2022
Post hoc analysis of a phase 3 study for treatment of uncontrolled focal seizures: Adjunctive cenobamate dose and seizure reduction by baseline seizure frequency.
Journal: Epilepsy research
Published: December 02, 2021
Long-term open-label perampanel: Generalized tonic-clonic seizures in idiopathic generalized epilepsy.
Journal: Epilepsia open
Published: November 09, 2021
A multivariable prediction model of a major treatment response for focal-onset seizures: A post-hoc analysis of Phase III trials of perampanel.
Journal: Epilepsy research
Published: November 16, 2020
Last Updated: 09/26/2026